Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer
Stopped Lack of funding
Conditions
- Anterior Urethral Cancer
- Localized Transitional Cell Cancer of the Renal Pelvis and Ureter
- Posterior Urethral Cancer
- Recurrent Bladder Cancer
- Recurrent Urethral Cancer
- Regional Transitional Cell Cancer of the Renal Pelvis and Ureter
- Stage III Bladder Cancer
- Transitional Cell Carcinoma of the Bladder
- Ureter Cancer
- Urethral Cancer Associated With Invasive Bladder Cancer
Interventions
- DRUG: cisplatin
- DRUG: gemcitabine hydrochloride
- DRUG: methotrexate
- DRUG: vinblastine
- DRUG: doxorubicin hydrochloride
- BIOLOGICAL: pegfilgrastim
- OTHER: laboratory biomarker analysis
Sponsor
University of Southern California
Collaborators